Clinical Trials
Oxford Covid-19 vaccine: Serum Institute begins clinical trial in India
Serum Institute of India’s trial for ‘Covishield’ vaccine developed by the University of Oxford started with the first patients screened by Bharati Vidyapeeth Deemed University (BVDU) Medical College and Hospital in Pune.
We have screened some patients. Tomorrow, we will...
Clinical Trials
Australian COVID-19 vaccine shows promising results in animal trials
A COVID-19 vaccine candidate being developed by Australia’s University of Queensland has shown “positive” results against the novel coronavirus in preclinical tests, raising hopes for its potential effectiveness and manufacturability, the varsity said on Wednesday.
According to the yet-to-be published...
News
India, Russia in talks over Covid vaccine production
The Russian vaccine, called Sputnik V, was the first to be approved for use anywhere in the world even though it is yet to undergo safety and efficacy trials large groups of human volunteers – one of the most...
News
Cryoport Announces Agreement to Acquire MVE Biological Solutions from Chart Industries
Cryoport, Inc., a global leader in temperature-controlled supply chain solutions for the life sciences industry, announced it has signed an agreement to acquire MVE Biological Solutions, a global leader in manufactured vacuum insulated products and cryogenic freezer systems for...
News
Pfizer and BioNTech Share Positive Early Data on Lead mRNA Vaccine Candidate BNT162b2 Against COVID-19
Pfizer Inc. and BioNTech SE shared additional Phase 1 safety and immunogenicity data from their ongoing U.S. study of the BNT162 mRNA-based vaccine program against SARS-CoV-2, which has advanced into Phase 2/3 evaluation. The newly released manuscript describes key...
News
Bristol Myers Squibb Enters Agreement to Acquire Forbius, Adding Lead TGF-beta Asset to Portfolio
Bristol Myers Squibb and Forbius, a privately held, clinical-stage protein engineering company that designs and develops biotherapeutics for the treatment of cancer and fibrotic diseases, announced that they have entered into a definitive agreement under which Bristol Myers Squibb...
Drug Research
Quanticate Announces new Partnership with Antev Ltd
Quanticate is pleased to partner with Antev Limited on a Phase II, Open-Label, Multicentre Study Investigating the Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of Teverelix Trifluoroacetate, a GnRH antagonist, in Participants with Advanced Prostate Cancer.
Prostate cancer is one of the...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.